Synovitis in systemic sclerosis is an interferon-driven stromal condition distinct from rheumatoid arthritis
Celina Geiß, Camino Calvo-Cebrián, Miranda Houtman, Ege Ezen, Katerina Apostolopoulou, Cristian Iperi, Melpomeni Toitou, Alexandra A. Khmelevskaya, Marija Lugar, Anne Cauvet, Yannis Djeffal, Mojca Frank‐Bertoncelj, Sam G. Edalat, Thomas Rauer, Katharina Zachariassen, , Muriel Elhaï
This study identifies SSc synovitis as an IFN-driven stromal condition distinct from RA, with implications for IFNAR1 blockade as a therapeutic strategy.
bioRxiv · Jul 2, 2026 · PreprintImmunology